← Eichor
Condition: Adolescents And Young Adults With Cancer Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Adolescents And Young Adults With Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT06847269DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · 70 location(s) · Fore Biotherapeutics · NCT05503797Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Phase 1 · 2 location(s) · University of Chicago · NCT03571321Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Phase 2 · 1 location(s) · New York Medical College · NCT02393157DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
NA · 5 location(s) · Virginia Commonwealth University · NCT05958316Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Phase 3 · 205 location(s) · Children's Oncology Group · NCT06513962HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignanci
Phase 1/Phase 2 · 36 location(s) · Princess Maxima Center for Pediatric Oncology · NCT05658640Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
NA · 1 location(s) · Northwestern University · NCT03932903Munich ME/CFS Cohort Study
Phase N/A · 1 location(s) · Technical University of Munich · NCT06005246International Leukemia Target Board
Phase N/A · 7 location(s) · Princess Maxima Center for Pediatric Oncology · NCT05270096Parental Support Intervention in an Advanced Oncological Context
NA · 1 location(s) · Université Libre de Bruxelles · NCT07341815Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06941324Digital Peer Navigation for Adolescents and Young Adults With Cancer
NA · 1 location(s) · University Health Network, Toronto · NCT06193369SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126A Study of Questionnaires in Adolescents and Young Adults With Cancer
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07212166The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults
Phase 2 · 24 location(s) · Pediatric Transplantation & Cellular Therapy Consortium · NCT03509961Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Phase 3 · 205 location(s) · AstraZeneca · NCT06079671Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
NA · 1 location(s) · Stanford University · NCT07220343Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )
Phase N/A · 13 location(s) · Associazione Italiana Ematologia Oncologia Pediatrica · NCT07368582A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adole
Phase 2 · 155 location(s) · National Cancer Institute (NCI) · NCT06124157DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770102Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
NA · 1 location(s) · Implenomics · NCT06004011DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05722886The Prospective Observational COMPRAYA Cohort Study
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT04682470RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
Phase N/A · 2 location(s) · Grupo Argentino de Tratamiento de la Leucemia Aguda · NCT05127148DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Canc
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770037Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT06458036
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.